Parkway Wealth Management Group LLC Purchases New Position in SPDR S&P Pharmaceuticals ETF $XPH
Parkway Wealth Management Group LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 380,824 shares of the company’s stock, valued at approximately $24,754,000. SPDR S&P Pharmaceuticals ETF comprises about 2.8% of Parkway […]
20 Oct 11:37 · The Markets Daily